These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22019723)

  • 1. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease.
    Mecocci P; Polidori MC
    Biochim Biophys Acta; 2012 May; 1822(5):631-8. PubMed ID: 22019723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conflict of evidence: carotenoids and other micronutrients in the prevention and treatment of cognitive impairment.
    Polidori MC; De Spirt S; Stahl W; Pientka L
    Biofactors; 2012; 38(2):167-71. PubMed ID: 22419511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidants for the treatment of mild cognitive impairment.
    Mecocci P; Mariani E; Cornacchiola V; Polidori MC
    Neurol Res; 2004 Jul; 26(5):598-602. PubMed ID: 15265281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease - challenges and perspectives.
    Polidori MC; Nelles G
    Curr Pharm Des; 2014; 20(18):3083-92. PubMed ID: 24079767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant strategies for Alzheimer's disease.
    Grundman M; Grundman M; Delaney P
    Proc Nutr Soc; 2002 May; 61(2):191-202. PubMed ID: 12133201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant approaches for the treatment of Alzheimer's disease.
    Lee HP; Zhu X; Casadesus G; Castellani RJ; Nunomura A; Smith MA; Lee HG; Perry G
    Expert Rev Neurother; 2010 Jul; 10(7):1201-8. PubMed ID: 20586698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
    Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
    Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum.
    Mecocci P
    J Alzheimers Dis; 2004 Apr; 6(2):159-63. PubMed ID: 15096699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium and Alzheimer's disease: a systematic review.
    Loef M; Schrauzer GN; Walach H
    J Alzheimers Dis; 2011; 26(1):81-104. PubMed ID: 21593562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in Alzheimer's disease: are we connecting the dots?
    Rosini M; Simoni E; Milelli A; Minarini A; Melchiorre C
    J Med Chem; 2014 Apr; 57(7):2821-31. PubMed ID: 24131448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment and preclinical Alzheimer's disease.
    Morris JC
    Geriatrics; 2005 Jun; Suppl():9-14. PubMed ID: 16025770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.
    Praticò D
    Trends Pharmacol Sci; 2008 Dec; 29(12):609-15. PubMed ID: 18838179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows.
    Praticò D
    Ann N Y Acad Sci; 2008 Dec; 1147():70-8. PubMed ID: 19076432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
    Behl C; Holsboer F
    Fortschr Neurol Psychiatr; 1998 Mar; 66(3):113-21. PubMed ID: 9565761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Expert Rev Neurother; 2015 Jan; 15(1):19-40. PubMed ID: 25243342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The status of ongoing trials for mild cognitive impairment.
    Sramek JJ; Veroff AE; Cutler NR
    Expert Opin Investig Drugs; 2001 Apr; 10(4):741-52. PubMed ID: 11281823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial treatment of tart cherry extract and essential fatty acids reduces cognitive impairments and inflammation in the mu-p75 saporin-induced mouse model of Alzheimer's disease.
    Matchynski JJ; Lowrance SA; Pappas C; Rossignol J; Puckett N; Sandstrom M; Dunbar GL
    J Med Food; 2013 Apr; 16(4):288-95. PubMed ID: 23566055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.